Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2018 - 2019)

Ironwood Pharmaceuticals' Cash from Discontinued Operations history spans 3 years, with the latest figure at 11364000.0 for Q1 2019.

  • For Q1 2019, Cash from Discontinued Operations changed N/A year-over-year to 11364000.0; the TTM value through Dec 2019 reached 11364000.0, up 281.73%, while the annual FY2019 figure was 11364000.0, 3.76% down from the prior year.
  • Cash from Discontinued Operations for Q1 2019 was 11364000.0 at Ironwood Pharmaceuticals, up from 3898000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 11364000.0 in Q1 2019 and bottomed at 2605000.0 in Q3 2018.